Live Webinar | Medicare Payment and Reimbursement
Live Webinar | Innovation and Disruption
Live Webinar | Patient Financial Communications
Live Webinar | Operations and Other Technology
Blog | Telemedicine

University of Rochester: Using telemedicine to reach more patients with Parkinson’s disease

Blog | Telemedicine

University of Rochester: Using telemedicine to reach more patients with Parkinson’s disease

  • The University of Rochester began pioneering the use of telemedicine to treat patients with Parkinson’s disease more than a decade ago.
  • The initiative started by linking specialists with patients in nursing homes before moving to providing virtual specialty care in the homes of patients.
  • Health system leaders, payers and legislators can pave the road to further expansion of such programs through physician training, expanded reimbursement policies and interstate licensure compacts.

Neurological disorders are now the world’s leading cause of disability, and the fastest growing among them is Parkinson’s disease. Each day, 10,000 Americans turn 65, and up to 700 of them will develop Parkinson’s. The number of people with Parkinson’s doubled from 1990 to 2015 and is expected to double again by 2040.

Ray Dorsey, MD
Alistair Glidden

Despite the growing disease burden, access to specialized care is poor, and often nonexistent, for those with Parkinson’s who cannot travel to major medical centers. Over 40% of Americans with Parkinson’s do not receive appropriate neurological care. Those patients face higher odds of falling, breaking a hip, moving into a skilled nursing facility and dying.

The global proliferation of broadband access and smartphone ownership is poised to bridge this gap in access. Telemedicine can reach individuals no matter their location or disease stage. From a cost standpoint, widespread use of telemedicine can reduce health systems’ reliance on expensive brick-and-mortar satellite clinics, eliminate time and travel costs for patients and remove the facility fees imposed on payers for in-person visits.

The biggest cost savings may stem from improved clinical outcomes. A single emergency department visit for a fall and broken hip can amount to $100,000 after factoring in all costs. A telemedicine visit, by comparison, may cost health systems $100 or less. If more frequent and convenient specialized care via telemedicine can prevent a fall in just one in every 1,000 patients, the system already will have paid for itself.

A New York pilot seeks to help afflicted patients

The University of Rochester has been pioneering the use of telemedicine for Parkinson’s disease for more than a decade. Early programs focused on nursing homes in rural New York, where many patients’ disease states were too advanced for them to travel to a specialist, while their locations precluded specialist travel to them.

After showing the feasibility of connecting specialists and institutions via telemedicine on a widespread basis, we began moving care directly into the patient’s home. A series of studies, which resulted in the first randomized controlled trial of in-home telemedicine for people with Parkinson’s, underscored the value, feasibility and acceptability of in-home telemedicine care. Almost all participants in the telemedicine arm completed at least one virtual visit, and overall satisfaction was 97%.

Through generous grants, we then launched Parkinson's Disease Care New York (PDCNY), the first statewide telemedicine program for Parkinson’s. Providing care for anyone in New York state, regardless of ability to pay, PDCNY has enrolled more than 400 individuals. Of these enrollees, 21% are homebound, 59% are from federally designated Health Professional Shortage Areas and only 50% received specialist care prior to enrollment. Among participants, 94% indicated that they were satisfied or very satisfied with the program.

The program now incorporates educational content and trained therapists throughout the state. As a result, quality of life (as measured by the disease-specific PDQ-39 scale) has improved among participants.

Seeking to expand the program’s scale and scope

PDCNY showed the feasibility of deploying a telemedicine care program for Parkinson’s at scale. However, the program faces constraints in both funding (reliance on grants) and access (only New York residents can receive care).

We will continue to expand in New York and are looking to develop alternative models — for example, an insurance-independent self-payment model; insurance coverage of direct in-home telemedicine; or telemedicine delivered at a clinic near a patient’s home, which is typically paid for by insurance — to sustain the program. We also are broadening outreach efforts to bring care to the most underserved populations, whether based on distance, disability or socioeconomic factors. We will expand to other states through partnerships with major academic medical centers, many of which have the infrastructure and policies to support large-scale adoption of telemedicine.

To broaden our reach further, we need the support of health system leaders, payers and legislators. Making telemedicine a standard component of physician training, as the University of Rochester has started to do, and expanding insurance coverage of telemedicine are essential to provide appropriate care for the growing number of patients with conditions that make traveling for medical care difficult.

Patients living in states with few specialists would benefit immensely from interstate licensure compacts that allow the provision of telemedicine care across state lines. The skill required to treat someone with Parkinson’s in Rhode Island does not change if the patient is located in Georgia, New Mexico or Oregon.

On the most basic level, we must recognize the potential of telemedicine to transform care and improve quality of life for hundreds of thousands of Americans with Parkinson’s and other chronic conditions. Patients are more than ready for this new care paradigm. Are we?

About the Authors

Ray Dorsey, MD,

is a neurology professor and director of the Center for Health + Technology, University of Rochester, Rochester, N.Y. (

Alistair Glidden

is a clinical research coordinator at the Center for Health + Technology (

Sign up for a free guest account and get access to five free articles every month.


Related Articles | Telemedicine

Blog | Contracting

2023 regulations for Medicare Advantage and ACA marketplaces seek to enhance network adequacy standards

HHS and CMS recently released sets of 2023 regulations that affect provider network adequacy standards in Medicare Advantage and the Affordable Care Act insurance marketplaces.

Article | Cost Effectiveness of Health

Telehealth is primed for growth despite post-lockdown fade

If our nation is to achieve true cost effectiveness of health, virtual healthcare must play a pivotal role. In this preview of the May 2022 hfm cover story, two health system leaders share lessons learned from their efforts to develop effective telehealth programs as a key component in their long-term value-focused care strategies, and two thought leaders weigh in on keys to telehealth success.

Blog | Coronavirus

HHS policy update: Recent developments include an extension of the public health emergency and notable progress in reducing the Medicare appeals backlog

HHS Secretary Xavier Becerra signed a 90-day extension of the COVID-19 public health emergency, ensuring the PHE will last until at least mid-July.

News | Coronavirus

More than 2 years into the pandemic, the issue of deferred care continues to affect the healthcare industry

Concerns about the implications of deferred care continue to grow as healthcare organizations establish their strategies for a post-pandemic landscape.